| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.13 | 8e-06 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.13 | 3e-05 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.32 | 0.001 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |